Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

Potentially Inappropriate Medications and Regimen Complexity on Readmission of Elderly Patients with Polypharmacy: A Retrospective Study

  • Sunmin Lee (Department of Pharmacy, Inha University Hospital)
  • Received : 2022.11.02
  • Accepted : 2022.12.27
  • Published : 2023.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Along with the increase in the elderly population, concerns about polypharmacy, which can cause medication-related problems, are increasing. This study aimed to find out the association between drug-related factors and readmission in elderly patients within 30 days after discharge. Methods: Data of patients aged ≥65 years who were discharged from the respiratory medicine ward of a tertiary hospital between January and March 2016 were retrospectively obtained. The medication regimen complexity at discharge was calculated using the medication regimen complexity index (MRCI) score, comorbidity status was assessed using the Charlson comorbidity index (CCI), potentially inappropriate medications (PIMs) were evaluated based on the Beer 2019 criteria, and adverse drug events (ADEs) were examined using the ADE reporting system. Multivariable logistic regression analysis was used to evaluate the effect of medication-related problems on hospital readmission after controlling for other variables. Results: Of the 206 patients included, 84 (40.8%) used PIMs, 31 (15%) had ADEs, and 32 (15.5%) were readmitted. The mean age, total medications, MRCI, CCI, and PIMs in the readmission group were significantly higher than those in the non-readmission group. Age significantly decreased the risk of readmission (odds ratio [OR], 0.89; 95% confidence interval [CI], 0.84-0.96) after adjusting for sex, length of hospital stay, and ADEs. The use of PIMs (OR, 2.38; 95% CI, 1.10-5.16) and increased CCI (OR, 1.50; 95% CI, 1.16-1.93) and MRCI (OR, 1.04; 95% CI, 1.01-1.07) were associated with an increased occurrence of readmission. Conclusion: PIMs were associated with a significantly greater risk for readmission than MRCI.

Keywords

References

  1. Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):1-10. https://doi.org/10.1186/s12877-016-0400-5
  2. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716-24. https://doi.org/10.1001/jama.294.6.716
  3. Ruberu RP, Fitzgerald SP. Clinical practice guidelines for chronic diseases--understanding and managing their contribution to polypharmacy. Clin Geriatr Med. 2012;28(2):187-98. https://doi.org/10.1016/j.cger.2012.01.003
  4. Jokanovic N, Tan EC, Dooley MJ, et al. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015;16(6):535.e1-12. https://doi.org/10.1016/j.jamda.2015.03.003
  5. Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63(2):187-95. https://doi.org/10.1111/j.1365-2125.2006.02744.x
  6. Mansur N, Weiss A, Beloosesky Y. Relationship of in-hospital medication modifications of elderly patients to postdischarge medications, adherence, and mortality. Ann Pharmacother. 2008;42(6):783-9. https://doi.org/10.1345/aph.1L070
  7. Elliott RA, O'Callaghan CJ. Impact of hospitalisation on the complexity of older patients' medication regimens and potential for regimen simplification. J Pharm Pract. 2011;41(1):21-5. https://doi.org/10.1002/j.2055-2335.2011.tb00060.x
  8. Chang WT, Kowalski SR, Sorich W, et al. Medication regimen complexity and prevalence of potentially inappropriate medicines in older patients after hospitalisation. Int J Clin Pharm. 2017;39(4):867-73. https://doi.org/10.1007/s11096-017-0490-y
  9. Wimmer BC, Cross AJ, Jokanovic N, et al. Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review. J Am Geriatr Soc. 2017;65(4):747-53. https://doi.org/10.1111/jgs.14682
  10. Paquin AM, Zimmerman KM, Kostas TR, et al. Complexity perplexity: a systematic review to describe the measurement of medication regimen complexity. Expert Opin Drug Saf. 2013;12(6):829-40. https://doi.org/10.1517/14740338.2013.823944
  11. George J, Phun Y-T, Bailey MJ, et al. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369-76. https://doi.org/10.1345/aph.1D479
  12. Lee S, Jang J, Yang S, et al. Development and validation of the Korean version of the medication regimen complexity index. PloS One. 2019;14(5):e0216805.
  13. Pantuzza LL, Ceccato M, Silveira MR, et al. Validation and standardization of the Brazilian version of the Medication Regimen Complexity Index for older adults in primary care. Geriatr Gerontol Int. 2018;18(6):853-9. https://doi.org/10.1111/ggi.13261
  14. Saez de la Fuente J, Such Diaz A, Canamares-Orbis I, et al. Cross-cultural Adaptation and Validation of the Medication Regimen Complexity Index Adapted to Spanish. Ann Pharmacother. 2016;50(11):918-25. https://doi.org/10.1177/1060028016656385
  15. Okuyan B, Babi B, Sancar M, et al. Validation of the Turkish version of medication regimen complexity index among elderly patients. J Eval Clin Pract. 2016;22(5):732-6. https://doi.org/10.1111/jep.12526
  16. Melchiors AC, Correr CJ, Fernandez-Llimos F. Translation and validation into Portuguese language of the medication regimen complexity index. Arq Bras Cardiol. 2007;89(4):210-8.
  17. Alves-Conceicao V, Rocha, KSS, Silva, FVN, et al. Medication Regimen Complexity Measured by MRCI: A Systematic Review to Identify Health Outcomes. Ann Pharmacother. 2018;52(11):1117-34. https://doi.org/10.1177/1060028018773691
  18. Panel AGSBCUE, Fick DM, Semla TP, et al. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674-94. https://doi.org/10.1111/jgs.15767
  19. Gillespie U, Alassaad A, Hammarlund-Udenaes M, et al. Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization-analyses from a randomized controlled trial. PloS One. 2013;8(5):e62401.
  20. Thillainadesan J, Gnjidic D, Green S, et al. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials. Drugs Aging. 2018;35(4):303-19. https://doi.org/10.1007/s40266-018-0536-4
  21. Vik SA, Hogan DB, Patten SB, et al. Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults. Drugs Aging. 2006;23(4):345-56. https://doi.org/10.2165/00002512-200623040-00007
  22. Farris KB, Kelly MW, Tryon J. Clock drawing test and medication complexity index as indicators of medication management capacity: a pilot study. J Am Pharm Assoc. 2003;43(1):78-81. https://doi.org/10.1331/10865800360467097
  23. Wimmer BC, Cross AJ, Jokanovic N, et al. Clinical outcomes associated with medication regimen complexity in older people: a systematic review. J Am Geriatr Soc. 2017;65(4):747-53. https://doi.org/10.1111/jgs.14682
  24. Van der Linden L, Decoutere L, Walgraeve K, et al. Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical Outcome. Drugs Aging 2017;34(2):123-33. https://doi.org/10.1007/s40266-016-0424-8
  25. Su S, Gao L, Ma W, et al. Number-dependent association of potentially inappropriate medications with clinical outcomes and expenditures among community-dwelling older adults: A population-based cohort study. Br J Clin Pharmacol. 2022;88(7):3378-91. https://doi.org/10.1111/bcp.15286
  26. Chang WT, Kowalski SR, Sorich W, et al. Medication regimen complexity and prevalence of potentially inappropriate medicines in older patients after hospitalisation. Int J Clin Pharm. 2017;39(4):867-73. https://doi.org/10.1007/s11096-017-0490-y
  27. Bazargan M, Smith J, Yazdanshenas H, et al. Non-adherence to medication regimens among older African-American adults. BMC Geriatr 2017;17(1):163.
  28. Frenkel WJ, Jongerius EJ, Mandjes-van Uitert MJ, et al. Validation of the Charlson Comorbidity Index in acutely hospitalized elderly adults: a prospective cohort study. J Am Geriatr Soc. 2014;62(2):342-6. https://doi.org/10.1111/jgs.12635
  29. Wimmer BC, Dent E, Bell JS, et al. Medication Regimen Complexity and Unplanned Hospital Readmissions in Older People. Ann Pharmacother. 2014;48(9):1120-8. https://doi.org/10.1177/1060028014537469
  30. Tesfaye WH, Peterson GM, Castelino RL, et al. Medication-related factors and hospital readmission in older adults with chronic kidney disease. J Clin Med. 2019;8(3):395.
  31. Tesfaye WH, Peterson GM, Castelino RL, et al. Medication regimen complexity and hospital readmission in older adults with chronic kidney disease. Ann Pharmacother. 2019;53(1):28-34. https://doi.org/10.1177/1060028018793419
  32. Reich O, Rosemann T, Rapold R, et al. Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization. PLoS One. 2014;9(8):e105425.
  33. Schoonover H, Corbett CF, Weeks DL, et al. Predicting potential postdischarge adverse drug events and 30-day unplanned hospital readmissions from medication regimen complexity. J Patient Saf. 2014;10(4):186-91. https://doi.org/10.1097/PTS.0000000000000067
  34. Willson MN, Greer CL, Weeks DL. Medication regimen complexity and hospital readmission for an adverse drug event. Ann Pharmacother. 2014;48(1):26-32. https://doi.org/10.1177/1060028013510898
  35. Liang CK, Chou MY, Hsu YH, et al. The association of potentially inappropriate medications, polypharmacy and anticholinergic burden with readmission and emergency room revisit after discharge: A hospital-based retrospective cohort study. Br J Clin Pharmacol. 2023;89(1):187-200. https://doi.org/10.1111/bcp.15457
  36. Counter D, Millar JWT, McLay JS. Hospital readmissions, mortality and potentially inappropriate prescribing: a retrospective study of older adults discharged from hospital. Br J Clin Pharmacol, 2018;84(8):1757-63. https://doi.org/10.1111/bcp.13607
  37. Sehgal V, Bajwa SJ, Sehgal R, Bajaj A, Khaira U, Kresse V. Polypharmacy and potentially inappropriate medication use as the precipitating factor in readmissions to the hospital. J Family Med Prim Care. 2013;2(2):194-9. https://doi.org/10.4103/2249-4863.117423
  38. Linkens AEMJH, Milosevic V, van der Kuy PHM, et al. Medication-related hospital admissions and readmissions in older patients: an overview of literature. Int J Clin Pharm. 2020;42(5):1243-51. https://doi.org/10.1007/s11096-020-01040-1
  39. Barlow A, Prusak ES, Barlow B, et al. Interventions to reduce polypharmacy and optimize medication use in older adults with cancer. J Geriatr Oncol. 2021;12(6):863-71. https://doi.org/10.1016/j.jgo.2020.12.007